With the announcement of Animas Vibe’s FDA approval in the United States and last week’s first shipments of Asante’s new MySnap reaching customers, it’s the perfect time for an insulin pump comparison. Which pump should you be using in 2015?
Category: CGMs, Meters & Pumps
The U.S. FDA has approved the Animas Vibe insulin pump and Continuous Glucose Monitoring (CGM) system for the management of insulin-requiring diabetes in adults ages 18 and older.
Novo Nordisk and Roche Diabetes Care have launched NovoRapid PumpCart, the first prefilled pump cartridge with an insulin analogue that has been specifically designed for insulin pumps. This new treatment solution, which contains Novo Nordisk's rapid-acting insulin NovoRapid (insulin aspart) is expected to make insulin pump therapy...
The FDA has approved Dexcom's CGM remote mobile communications device: Dexcom SHARE. Dexcom SHARE, an accessory to the Dexcom G4 PLATINUM Continuous Glucose Monitoring System, uses a secure wireless connection to transmit the glucose levels of a person with diabetes to the smartphones
Medtronic has begun enrolling patients in an investigational device exemption (IDE) study of its new and innovative Predictive Low Glucose Management (PLGM) technology. The start of this study marks a critical step toward development of an artificial pancreas in the U.S. market.
CGM in the Cloud is a concept first put forward by engineer (and father of a young son with type 1) John Costik early last year that, in a nutshell, entails taking a patient’s CGMs device real-time data, sending it to the cloud, and then allowing access to that data – again, in real-time – in remote locations, such as a webpage, a cell phone, or a wearable, like the popular Pebble smartwatch.
Abbott has received CE Mark for its its revolutionary CGM system, the FreeStyle Libre Flash Glucose Monitoring System, which uses a new glucose sensing technology. The system eliminates the need for routine finger pricks, reading glucose levels through a sensor that can be worn on the back of the upper arm for up to 14 days. In addition, no finger prick calibration is needed--a key differentiator from current continuous glucose monitoring systems.
In a recent diaTribe interview with David Panzirer and Dana Ball, two of the main figures behind the Helmsley Charitable Trusts’s Type 1 Diabetes program, both men were asked what would be the most important advance in type 1 diabetes over the next five or ten years. Both men answered that improved continuous glucose monitoring technology has the potential to revolutionize the lives of people with type 1 diabetes.
iHealth Lab Inc. has announced the launch of the iHealth Align, the world’s smallest, FDA-approved mobile blood glucose monitor. The meter plugs directly into a smart phone and displays and stores readings using the iHealth Gluco-Smart app...
The U.S. Food and Drug Administration (FDA) has given its approval for the Dexcom G4 PLATINUM Professional continuous glucose monitoring system (CGM). The Dexcom G4 PLATINUM Professional is the only professional-version CGM that offers real-time, unblinded feedback allowing the patient to experience the full benefits of real-time CGM...